A national precision cancer medicine implementation initiative for Norway

Kjetil Taskén^{1

2}, Hege E G Russnes^{3

4

5}, Eline Aas^{6

7}, Line Bjørge^{8

9

10}, Egil S Blix^{11

12}; CONNECT Public–Private Partnership Consortium; Espen Enerly¹³, Gro L Fagereng¹⁴, Åsmund Flobak^{15

16}, Bjørnar Gilje¹⁷, Bjørn T Gjertsen^{9

10

18}, Tormod K Guren¹⁹, Jutta Heix²⁰, Eivind Hovig^{21

22}, Randi Hovland²³; InPreD-Norway and National Molecular Tumor Board Consortium; IMPRESS-Norway Consortium; Per E Lønning^{10

24}, Leonardo A Meza-Zepeda^{21

25}, Per M Mæhle²⁶, Hilde L Nilsen^{3

27}, Steinar Ø Thoresen^{20

28}, Ketil Widerberg²⁰, Sigbjørn Smeland^{3

26}, Åslaug Helland^{3

5

19}

Collaborators, Affiliations

Collaborators

Terje C Ahlquist, Nyosha Alikhani, Ali Areffard, Eli Bergli, Hege Edvardsen, Gry Festervoll, Grethe S Foss, Petter Foss, Ingvild Hagen, Kåre B Hagen, Håvard H Hauge, Bjorn V Herikstad, Kristian Hveem, Elisabeth Jarnaess, Kristin Kittelsen, Kristin Krogsrud, Monica Larsen, Mariam Lofwander, Birgitte Lygren, Aslaug Muggerud, Cathrine S Notland, Ole A Oppdalshei, Ravinder Singh, Svein Skeie, Fredrik Sund, Lars P Strand, Lidziya Ulvenes, Giske Ursin, Sverrir Valgardsson, Pål Wiik, Naoko Yamagata, Thomas Berg, Diana L Bordin, Hans-Rickard Brattbakk, Richard Doughty, Kari Ersland, Rakel Forthun, Einar Gudlaugsson, Hanne Hamre, Hans Kristian Haugland, Emiel Janssen, Mari Jebens, Tonje Lien, Susanne Lorenz, Torben Lüders, Pitt Niehusmann, John C Noone, Vigdis Nygaard, Ulla Randen, Anne Renolen, Anne J Skjulsvik, Sigmund V Sperstad, Olav K Vintermyr, Daniel Vodak, Teresia Wangensteen, Ragnhild M Wold, Kristin Åberg, Gro Live Fagereng, Khalid Al-Shibli, Yvonne Andersson, Egil Blix, Bodil Bjerkehagen, Sigmund Brabrand, Odd Terje Brustugun, Marte G Cameron, Astrid Dalhaug, Dalia Dietzel, Tom Dønnem, Ragnhild S Falk, Sverre Fluge, Bjørn H Grønberg, Kari Grønås, Hanne Hamre, Åse Haug, Daniel Heinrich, Geir Olav Hjortland, Gunnar Houge, Ann-Charlotte Iversen, Stian Knappskog, Jon Amund Kyte, Hedda von der Lippe Gythfeldt, Kristina Lindemann, Ragnhild A Lothe, Jo-Åsmund Lund, Per Eystein Lønning, Leonardo Meza-Zepeda, Monica C Munthe-Kaas, Olav T D Nguyen, Pitt Niehusmann, Katarina Puco, Anne H Ree, Tonje B Riste, Karin Semb, Eli Sihn S Steinskog, Andreas Stensvold, Pål Suhrke, Øyvind Tennøe, Geir E Tjønnfjord, Liv J Vassbotn, Sissel F Wahl

Affiliations

¹ Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. Kjetil.tasken@medisin.uio.no.
² Institute of Clinical Medicine, University of Oslo, Oslo, Norway. Kjetil.tasken@medisin.uio.no.
³ Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
⁴ Department of Pathology, Oslo University Hospital, Oslo, Norway.
⁵ Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
⁶ Department of Health Management and Health Economics, Institute of Health and Society, University of Oslo, Oslo, Norway.
⁷ Division of Health Services, Norwegian Institute of Public Health, Oslo, Norway.
⁸ Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
⁹ Centre for Cancer Biomarkers CCBIO, University of Bergen, Bergen, Norway.
¹⁰ Department of Clinical Science, University of Bergen, Bergen, Norway.
¹¹ Department of Oncology, University Hospital of North Norway, Tromsø, Norway.
¹² Institute of Clinical Medicine, UiT - The Arctic University of Norway, Tromsø, Norway.
¹³ Department of Research, Cancer Registry of Norway, Oslo, Norway.
¹⁴ Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
¹⁵ The Cancer Clinic, St. Olav University Hospital, Trondheim, Norway.
¹⁶ Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
¹⁷ Department of Oncology, Stavanger University Hospital, Stavanger, Norway.
¹⁸ Haematology Section, Department of Medicine, Haukeland University Hospital, Bergen, Norway.
¹⁹ Department of Oncology, Oslo University Hospital, Oslo, Norway.
²⁰ CONNECT Public-Private Partnership, Oslo Cancer Cluster SA, Oslo, Norway.
²¹ Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
²² Centre for Bioinformatics, Department of Informatics, University of Oslo, Oslo, Norway.
²³ Section for Cancer Genomics, Haukeland University Hospital, Bergen, Norway.
²⁴ Department of Oncology, Haukeland University Hospital, Bergen, Norway.
²⁵ Department of Core Facilities, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
²⁶ Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.
²⁷ Department of Clinical Molecular Biology, Akershus University Hospital, Lørenskog, Norway.
²⁸ Merck AB NUF, Oslo, Norway.

PMID: 35513529
DOI: 10.1038/s41591-022-01777-4

A national precision cancer medicine implementation initiative for Norway

Kjetil Taskén et al. Nat Med. 2022 May.

. 2022 May;28(5):885-887.

doi: 10.1038/s41591-022-01777-4.

Authors

Collaborators

Terje C Ahlquist, Nyosha Alikhani, Ali Areffard, Eli Bergli, Hege Edvardsen, Gry Festervoll, Grethe S Foss, Petter Foss, Ingvild Hagen, Kåre B Hagen, Håvard H Hauge, Bjorn V Herikstad, Kristian Hveem, Elisabeth Jarnaess, Kristin Kittelsen, Kristin Krogsrud, Monica Larsen, Mariam Lofwander, Birgitte Lygren, Aslaug Muggerud, Cathrine S Notland, Ole A Oppdalshei, Ravinder Singh, Svein Skeie, Fredrik Sund, Lars P Strand, Lidziya Ulvenes, Giske Ursin, Sverrir Valgardsson, Pål Wiik, Naoko Yamagata, Thomas Berg, Diana L Bordin, Hans-Rickard Brattbakk, Richard Doughty, Kari Ersland, Rakel Forthun, Einar Gudlaugsson, Hanne Hamre, Hans Kristian Haugland, Emiel Janssen, Mari Jebens, Tonje Lien, Susanne Lorenz, Torben Lüders, Pitt Niehusmann, John C Noone, Vigdis Nygaard, Ulla Randen, Anne Renolen, Anne J Skjulsvik, Sigmund V Sperstad, Olav K Vintermyr, Daniel Vodak, Teresia Wangensteen, Ragnhild M Wold, Kristin Åberg, Gro Live Fagereng, Khalid Al-Shibli, Yvonne Andersson, Egil Blix, Bodil Bjerkehagen, Sigmund Brabrand, Odd Terje Brustugun, Marte G Cameron, Astrid Dalhaug, Dalia Dietzel, Tom Dønnem, Ragnhild S Falk, Sverre Fluge, Bjørn H Grønberg, Kari Grønås, Hanne Hamre, Åse Haug, Daniel Heinrich, Geir Olav Hjortland, Gunnar Houge, Ann-Charlotte Iversen, Stian Knappskog, Jon Amund Kyte, Hedda von der Lippe Gythfeldt, Kristina Lindemann, Ragnhild A Lothe, Jo-Åsmund Lund, Per Eystein Lønning, Leonardo Meza-Zepeda, Monica C Munthe-Kaas, Olav T D Nguyen, Pitt Niehusmann, Katarina Puco, Anne H Ree, Tonje B Riste, Karin Semb, Eli Sihn S Steinskog, Andreas Stensvold, Pål Suhrke, Øyvind Tennøe, Geir E Tjønnfjord, Liv J Vassbotn, Sissel F Wahl

Affiliations

¹ Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. Kjetil.tasken@medisin.uio.no.
² Institute of Clinical Medicine, University of Oslo, Oslo, Norway. Kjetil.tasken@medisin.uio.no.
³ Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
⁴ Department of Pathology, Oslo University Hospital, Oslo, Norway.
⁵ Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
⁶ Department of Health Management and Health Economics, Institute of Health and Society, University of Oslo, Oslo, Norway.
⁷ Division of Health Services, Norwegian Institute of Public Health, Oslo, Norway.
⁸ Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
⁹ Centre for Cancer Biomarkers CCBIO, University of Bergen, Bergen, Norway.
¹⁰ Department of Clinical Science, University of Bergen, Bergen, Norway.
¹¹ Department of Oncology, University Hospital of North Norway, Tromsø, Norway.
¹² Institute of Clinical Medicine, UiT - The Arctic University of Norway, Tromsø, Norway.
¹³ Department of Research, Cancer Registry of Norway, Oslo, Norway.
¹⁴ Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
¹⁵ The Cancer Clinic, St. Olav University Hospital, Trondheim, Norway.
¹⁶ Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
¹⁷ Department of Oncology, Stavanger University Hospital, Stavanger, Norway.
¹⁸ Haematology Section, Department of Medicine, Haukeland University Hospital, Bergen, Norway.
¹⁹ Department of Oncology, Oslo University Hospital, Oslo, Norway.
²⁰ CONNECT Public-Private Partnership, Oslo Cancer Cluster SA, Oslo, Norway.
²¹ Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
²² Centre for Bioinformatics, Department of Informatics, University of Oslo, Oslo, Norway.
²³ Section for Cancer Genomics, Haukeland University Hospital, Bergen, Norway.
²⁴ Department of Oncology, Haukeland University Hospital, Bergen, Norway.
²⁵ Department of Core Facilities, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
²⁶ Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.
²⁷ Department of Clinical Molecular Biology, Akershus University Hospital, Lørenskog, Norway.
²⁸ Merck AB NUF, Oslo, Norway.

PMID: 35513529
DOI: 10.1038/s41591-022-01777-4

No abstract available

PubMed Disclaimer

References

1. Von Hoff, D. D. et al. J. Clin. Oncol. 28, 4877–4883 (2010). - DOI
1. Jardim, D. L. et al. J. Natl. Cancer Inst. 107, djv253 (2015). - DOI
1. Le Tourneau, C. et al. Lancet Oncol. 16, 1324–1334 (2015). - DOI
1. IMPRESS-Norway. Clinical trial for cancer patients; https://impress-norway.no/ (2021).
1. van der Velden, D. L. et al. Nature 574, 127–131 (2019). - DOI

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

A national precision cancer medicine implementation initiative for Norway

Collaborators

Affiliations

A national precision cancer medicine implementation initiative for Norway

Authors

Collaborators

Affiliations

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical